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Adenylate kinases (AK) play a key role in nucleotide signaling processes and energy metabolism by
catalyzing the reversible conversion of ATP and AMP to 2 ADP. In the malaria parasite Plasmodium
falciparum this reaction is mediated by AK1, AK2, and a GTP:AMP phosphotransferase (GAK). Here,
we describe two additional adenylate kinase-like proteins: PfAKLP1, which is homologous to human
AK6, and PfAKLP2. Using GFP-fusion proteins and life cell imaging, we demonstrate a cytosolic local-
ization for PfAK1, PfAKLP1, and PfAKLP2, whereas PfGAK is located in the mitochondrion. PfAK2 is
located at the parasitophorous vacuole membrane, and this localization is driven by N-myristoyla-
tion.
Structured summary of protein interactions:
EXP-1 and PfAK2 colocalize by ﬂuorescence microscopy (View interaction)
PfAK2 and SERP colocalize by ﬂuorescence microscopy (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction and AMP [5]. Interestingly, PfAK2 can be N-myristoylated andMalaria still is a great socioeconomic and health problem
responsible for 655000 to around 1.24 million deaths and 216 mil-
lion infections in 2010 [1,2]. Due to the absence of a vaccine and
increasing resistance to current drugs, new chemotherapeutical
approaches are urgently needed [3].
Adenylate kinase (AK, EC 2.7.4.3, ATP + AMP, 2 ADP) catalyzes
the reversible high energy phosphoryl transfer from ATP to AMP
forming ADP and is involved in energy, metabolic, and signaling
pathways [4]. Two AKs (PfAK1, PfAK2) and a GTP:AMP phospho-
transferase (PfGAK, EC 2.7.4.10, GTP + AMP, GDP + ADP) were
characterized in the malaria parasite Plasmodium falciparum [5,6].
Recombinant PfAK1 displays the highest speciﬁcities for AMP and
ATP as substrates, whereas PfGAK exhibits a preference for GTPchemical Societies. Published by E
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cker).forms a heterodimer with N-myristoyltransferase [6]. PfAK1 has
been hypothesized to be located in mitochondria, since it contains
an N-terminal amphipathic helix (residues 118–130) that could
function as a mitochondrial import signal [5]. While most GAKs
are located in the mitochondrial matrix, PfGAK has been predicted
(PlasmoAP4.4, PlasmoDB) to be targeted to the apicoplast, a non-
photosynthetic plastid found in Apicomplexa. For PfAK2, no target
signals could be identiﬁed when using the prediction programs
PlasmoAP and PlasMit [6].
As reported here, a new putative AK (PFA0530c, adenylate
kinase-like protein 1, PfAKLP1) from P. falciparum is homologous
to human AK6. Additionally, a second protein (PFI1550c, PfAKLP2)
was predicted to belong to the AK family. We cloned and heterolo-
gously overexpressed these two AK-like proteins. Furthermore, we
systematically studied the subcellular localization of all Plasmodium
AK isoforms, and showed that N-myristoylation is required to target
PfAK2 to the parasitophorous vacuole membrane (PVM).
2. Materials and methods
2.1. PCR ampliﬁcation, sequencing, and subcloning of PfAKLP1 and
PfAKLP2
In order to amplify the PfAKLP1-encoding sequence, a gameto-
cyte as well as a blood stage cDNA library of P. falciparum 3D7 were
successfully employed.lsevier B.V. All rights reserved.
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reverse (50-AACTCGAGTATATATGAGAGAACCCAATTTTTTA-30) prim-
ers (Euroﬁns MWG Operon) with NdeI and XhoI restriction sites
(underlined) were used (PCR: 94 C for 3 min; 94 C for 30 s,
55 C for 45 s, 72 C for 90 s, 30 cycles; 72 C for 10 min). The
ampliﬁed sequence was cloned into a pGEM-T easy vector (Prome-
ga) for sequencing. The correct PfAKLP1 gene without stop codon
(558 bp) was then subcloned into the expression vector pET24a
(aklp1/pET24a) with a C-terminal hexahistidyl (His)-tag.
For ampliﬁcation of the PfAKLP2-encoding sequence, two prim-
ers (50-ATATGGATCCGAAACACTTCTACATAGCGAAATAT-30 and 50-
ATATCTCGAGTT ACCTTATATAGGAAAGAACTTGG-30, (Euroﬁns
MWG Operon)) with restriction sites for BamHI and XhoI (under-
lined) were employed. This led to the ampliﬁcation of an approxi-
mately 790 bp product by PCR (94 C for 3 min; 94 C for 30 s, 57 C
for 50 s, 72 C for 120 s, 30 cycles; 72 C for 10 min) from a game-
tocyte as well as a blood stage cDNA library of P. falciparum 3D7.
The PCR product was cloned into a pGEM-T easy vector for
sequencing. The fragment with the correct sequence was then sub-
cloned into pET28a (Novagen) (aklp2/pET28a) with an N-terminal
His-tag.
2.2. Heterologous overexpression and puriﬁcation of PfAKLP1 and
PfAKLP2
The construct aklp1/pET24a was transformed into Escherichia
coli KRX cells (Promega). Cells were grown at 37 C in Terriﬁc Broth
medium containing 50 lg/ml kanamycin. The overexpression was
induced by 0.1% (w/v) rhamnose and the culture was further
grown at 30 C for 15 h. Cells were harvested and lysed by the
addition of lysozyme and DNase and sonication in the presence
of protease inhibitors. The recombinant protein was puriﬁed via
a nickel-nitrilotriacetate (Ni–NTA) column (Qiagen).
Overexpression and puriﬁcation of PfAKLP2 were carried out as
described for PfAKLP1, but ProtinoR Ni-TED resin (Macherey–
Nagel) was used instead of Ni–NTA for the puriﬁcation.
2.3. Gel ﬁltration
PfAKLP1 and PfAKLP2 were further puriﬁed by gel-ﬁltration
chromatography on a HiLoad 16/60 Superdex 200 prep-grade col-
umn connected to an ÄKTA FPLC system (Amersham Pharmacia
Biotech). The column was calibrated with a gel-ﬁltration standard
(Amersham Pharmacia Biotech) and equilibrated with buffer con-
taining 50 mM sodium phosphate, 300 mM NaCl, pH 8.0. Proteins
in eluate fractions were detected spectrophotometrically at
280 nm. The protein fractions containing PfAKLP1 and PfAKLP2
were concentrated with a 3 kDa viva spin column (Sartorius Ste-
dim Biotech). Protein concentrations were determined using the
Bradford protein assay [7]. Purity of the recombinant proteins
was veriﬁed by SDS–PAGE.
2.4. Enzyme activity assays
The AK assay used is based on the determination of NDP with
pyruvate kinase and lactate in a coupled assay system [8]. The en-
zyme assay mixture contained 200 lM NADH, 10 U/ml lactate
dehydrogenase (Roche), 10 U/ml pyruvate kinase (Roche), 2.3 mM
NMP, 0.8 mM NTP, and rate-limiting quantities of PfAKLP1 or
PfAKLP2 in 1.5 mM MgCl2, 90 mM KCl, 110 mM triethanolamine-
HCl, pH 7.6, at 25 C. The consumption of NADH (e340nm =
6.22 mM1 cm1) was measured spectrophotometrically at
340 nm. In order to determine the substrate speciﬁcity, we tested
AMP, CMP, UMP, IMP, and GMP as substrates while using ATP as
the phosphate donor. The NTPs were also studied by testing ATP,GTP, ITP, and UTP as phosphate donors with AMP as described in
[5,6].
2.5. Construction of the GFP fusion vector
In order to investigate the localization of all AKs in P. falciparum,
we designed primers to insert BglII and AvrII restriction sites at the
ends of the genes of PfAK1, PfAK2, PfGAK, and PfAKLP1. The genes
were cloned into a pARL-1a+ shuttle vector, which contains a low-
expression CRT promoter and allows episomal gene expression as
described previously [11]. The transfection vectors containing the
fusion constructs were veriﬁed by sequencing, transformed in
E. coli, and puriﬁed from E. coli using a Qiagen Maxi Kit (Qiagen).
Because of an AvrII restriction site in PfAKLP2, we ﬁrst intro-
duced a silent mutation to remove the AvrII restriction site. Subse-
quently, we constructed a GFP fusion vector for the PfAKLP2 gene
as described above.
2.6. Site directed mutagenesis
Glycine in position 2, the N-myristoylation site of PfAK2 [6],
was mutated to an alanine. PCR for site-directed mutagenesis
of PfAK2 was performed with a Pfu polymerase (Promega) using
primers carrying the respective mutated codon: 50-GAGATCT
ATGGCATCATGTT ATAGTAGAAAAAAT-30, 50-ATTTTTTCTACTATAA
CATGATGCCATAGATCTC-30 (Euroﬁns MWG Operon); the mutated
codon is underlined. PCR templates were removed by digestion
with DpnI, and the PCR product was subsequently transformed
into competent E. coli XL1-Blue cells. The introduction of the cor-
rect mutation into the gene sequence was veriﬁed by sequencing,
and a GFP-fusion construct of PfAK2G2A was created as described
above.
2.7. Parasite transfection and immunoﬂuorescence
Blood stages of P. falciparum 3D7 were grown in continuous cul-
ture as described previously [9]. Electroporation was applied to
transfect Plasmodium falciparum 3D7 with pARL-1a+ vectors
containing the respective GFP-AK fusion constructs. Transfected
parasites were selected under drug pressure with 2 nM WR99210
(kindly supplied by D. Jacobus, Princeton, New Jersey, USA) as
described previously [10]. Live cell immunoﬂuorescence images
of the parasites were determined as described before [11].
2.8. Western blot analysis
The transgenic parasites were maintained as described [9].
Parasitized red blood cells with P. falciparum at the trophozoite
stage (IRBC) were enriched using LD-columns (MACS, Miltenyi Bio-
tec) [12]. IRBCs were harvested at 300 g for 3 min at room temper-
ature and resuspended in 50 ll 10 mM Tris pH 7.4, containing
protease inhibitors (Complete, Roche). IRBCs were lysed by three
freezing-thawing cycles using liquid nitrogen, and the lysate was
centrifuged at 50000g for 30 min at 4 C. The supernatant con-
taining the erythrocyte cytosol and parasite cytosol was trans-
ferred to a new tube and centrifuged two more times in order to
remove any remaining contamination with the membrane fraction.
The membrane pellet derived from the ﬁrst centrifugation of the
lysate was washed once with 1 ml and twice with 100 ll of the
Tris-buffer.
The Western blots were performed by using anti-GFP (1:1000,
Roche), anti-Hsp70 (1:1000, T. Blisnick, Paris), and anti-Exp1
(1:500, Jude Przyborski) antibodies, respectively, followed by
HRP-conjugated secondary anti-mouse antibodies (1:10000,
Jackson ImmunoResearch).
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3.1. PfAKLP1 and PfAKLP2
In the Plasmodium database PlasmoDB, two new putative AKs
were predicted and shown to be expressed throughout the parasite
blood and gametocyte stages with slightly higher expression of
Pfaklp2. cDNA libraries from Pf3D7 blood stages and gametocytes
were used as templates for the successful PCR ampliﬁcation of
the Pfaklp1 and Pfaklp2 genes.Fig. 1. Multiple sequence alignment of PfAKLP1 (XP_001351038), PfAKLP2 (XP_00280897
AK6 (NP_057367) and Trypanosoma brucei adenylate kinase B (XP_822341). Amino acid
frame, amino acids responsible for AMP binding are indicated by solid circles. The conser
The polybasic stretch of amino acids related to membrane association is marked by a
(underlined) is given in the box. The alignment was created by using Clustal Omega.The Pfaklp1 gene (PFA0530c) is located on chromosome 1 and
consists of one exon with 561 bp. A homology search on NCBI
showed 33% amino acid identity compared to human AK 6, which
has AK activity and is located in the nucleus [13]. Moreover,
PfAKLP1 shows the highest similarity (64% identity) to a hypothet-
ical protein related to nucleotide kinase in Plasmodium knowlesi,
while the sequences of PfAK1 and PfAKLP1 only share 25% identi-
ties. A multiple sequence alignment (Fig. 1) shows that most amino
acids of the canonic phosphoryl-binding loop GxxGxGxxT in
PfAKLP1 (G12, G17, K18, T20 for ATP binding; K18 and L75 for9), PfAK1 (XP_001347371), PfAK2 (XP_001349355), PfGAK (XP_001351464), human
s forming the canonic phosphoryl loop (P-loop, GxxGxGxxT) are demonstrated in a
ved residues labeled by solid triangles play a role in the catalytic mechanism of AKs.
horizontal black arrow. The myristoylated glycine within the myristoylation motif
Fig. 2. SDS–PAGE and Western Blot of recombinant PfAKLP1 and PfAKLP2. (A) and
(B), recombinant PfAKLP1 and PfAKLP2 on SDS–PAGE after Coomassie staining. (C)
and (D), Western blot of recombinant PfAKLP1 and PfAKLP2 using an anti-His
antibody.
3040 J. Ma et al. / FEBS Letters 586 (2012) 3037–3043AMP binding) are conserved [6], while a number of residues typi-
cally involved in AMP binding (L63, R64, G84, V87, V92, G113,
R116, Q120 in PfAK1) are missing in PfAKLP1. Residues contribut-
ing to transition state stabilization are conserved at positions 127
and 172 in PfAKLP1 (Fig. 1) [14,15].
Heterologous overexpression of Pfaklp1 in E. coli yielded a
25 kDa protein with a C-terminal hexahistidly-tag, which wasFig. 3. Localization of P. falciparum AKs fused to GFP. Cytosolic targeting of PfAK1 (A), Pf
shown by co-localization with anti-GFP antibody and the mitochondrial dye MitoTrackepuriﬁed by Ni–NTA afﬁnity chromatography followed by gel ﬁltra-
tion chromatography (Fig. 2A and C). The maximum yield of pure
protein reached about 4 mg/L E. coli culture. The speciﬁc activity
of PfAKLP1 was approximately 3 mU/mg with ATP and AMP as sub-
strates. In order to study if the His-tag affects the enzymatic activ-
ity of PfAKLP1, we subcloned the Pfaklp1 gene into the vector
pET28a, adding a His-tag to the N-terminus that can be cleaved
off by thrombin after puriﬁcation. However, there was no differ-
ence in speciﬁc activity of recombinant PfAKLP1 with C-terminal
or N-terminal His-tag or with and without N-terminal His-tag.
The open reading frame of Pfaklp2 (PFI1550c) positioned on
chromosome 9 has 792 bp including 4 exons. The gene is expressed
in all stages and has an expression peak in late schizonts. A se-
quence alignment revealed that the amino acids for substrate bind-
ing are hardly conserved in PfAKLP2. While V111, I116, G139, and
Q146 are reminiscent of AMP binding in PfAKLP2, the sequence of
the canonic P-loop is – apart from G65 – not noticeable (Fig. 1)
[5,14,15]. The yield of recombinant PfAKLP2 with 90% purity was
about 1.5 mg/L E. coli culture (Fig. 2B and D). However, recombi-
nant PfAKLP2 was not found to be active in the enzymatic assay de-
scribed above. The low or absent enzyme activity is indicative that
our puriﬁed proteins are not contaminated with E. coli AK. After
removing the His-tag by thrombin, we did not detect AK activity
of PfAKLP2, either.
A phylogenetic tree (Supplementary Fig. 1) was constructed
based on multiple sequences with high similarity of various AKs.
It became obvious that the subfamilies of PfAK1 and PfGAK are
conserved in closely related organisms. Accordingly, PfAK2 and
PfAKLP2 are clustered separately to distant subgroups of AK whenAKLP1 (B), and PfAKLP2 (C). Line (D) illustrates mitochondrial targeting of PfGAK as
rOrange. Scale bar, 3 lm.
J. Ma et al. / FEBS Letters 586 (2012) 3037–3043 3041compared to PfAK1 and PfGAK. In the phylogenetic tree, the branch
of PfAK2 is closer to the group including PfAK1 and PfGAK, while
the cluster of PfAKLP2 belongs to the group comprising PfAKLP1
and human AK6.
3.2. Localization of PfAK1, PfAK2, PfGAK, PfAKLP1, and PfAKLP2
3.2.1. Localization of AKs and GAK in Plasmodium
The immunoﬂuorescencemicroscopic examination of transgenic
parasites revealed the subcellular localization of all Plasmodium
AKs. PfAK1, PfAKLP1, and PfAKLP2 were located in the parasite
cytosol (Fig. 3A–C). Immunoﬂuorescence analyses suggest that
PfGAK is located in the mitochondrion, as seen by co-localization
of the GFP and mitotracker signals (Fig. 3D).
3.2.2. Localization and N-myristoylation of PfAK2
Interestingly, PfAK2 localized to a ring-like structure around the
parasite, and ‘‘loops’’ apparently connected to the PVM (Fig. 4A,
Fig. 5). This was highly indicative of a localization to the PV. Indeed,
co-localization analysis shows that PfAK2-GFP co-localizes with
the PV resident protein SERP (Fig. 5A). SERP seems to be excluded
from the ‘‘loops’’ suggesting that PfAK2-GFP in actual fact associ-
ates with the membrane of the PV, rather than being found in a sol-
uble state in the PV lumen. Staining of parasites with the
membrane stain Bodipy-TR-ceramide and co-localization with an
anti-Exp1 antibody indeed veriﬁed that the loops contain membra-
nous material (Fig. 5B and C). Taken together, these data suggest
that PfAK2 localizes to the PVM. Parasite proteins secreted beyond
the boundary of the parasite’s plasma membrane commonly con-
tain an N-terminal secretory signal sequence. Since PfAK2 lacked
such a signal, we wished to study its mode of trafﬁcking to the
PVM. A mutant of PfAK2 lacking the target site of N-myristoylation
(PfAK2G2A) was constructed and transfected into P. falciparum.Fig. 4. Subcellular localizations of PfAK2 and PfAK2G2A in P. falciparum. (A) Localization
transfected with AK2-GFP constructs using anti-Exp1 as a marker for the membrane frac
Cytosolic localization of PfAK2G2A. (D) Western blot of parasites transfected with the AK2
the parasite plasma membrane plus erythrocyte membrane plus parasitophorous vacuoPfAK2G2A was clearly located in the cytosol (Fig. 4C), thus demon-
strating that N-myristoylation of the protein is required to target
PfAK2 to the PVM. Western blots using an anti-GFP antibody con-
ﬁrmed that PfAK2 is indeed associated with the membrane, while
PfAK2G2A was found in the soluble fraction. To control the separa-
tion of membrane and cytosolic fractions of the parasite, antibodies
reacting with the membrane protein Exp1 and the cytosolic pro-
tein Hsp70 were employed. As shown in Fig. 5B and D, the majority
of PfAK2 was found in the parasite pellet, while most of PfAK2G2A
could be detected in the cytosolic fraction of the parasitized
erythrocytes.
4. Discussion
Analyzing the subcellular distribution of AK isoenzymes in
Plasmodium indicates that they are located in different compart-
ments, which allows for an efﬁcient network of energy supply
and consumption.
In P. falciparum, two adenylate kinases and one GTP:AMP phos-
photransferase were characterized [5,6]. In humans, eight AKs with
different tissue speciﬁcities and kinetic properties have been allo-
cated to speciﬁc subcellular compartments [4,16]. Human AK6 in
the nucleus negatively regulates the number of Cajal bodies, which
are nuclear organelles involved in the maturation of small nuclear
ribonucleoproteins, showing that isoforms of AK exert very differ-
ent functions [17].
When analyzing PlasmoDB, two additional AKs in P. falciparum
are predicted. PfAKLP1 shows homology to human AK6 (coilin
interacting with nuclear ATPase protein), which is an atypical AK
with an unusually broad substrate speciﬁcity, nuclear localization,
and structural features of ATPase/GTPase proteins [18]. However,
the distinct localization of PfAKLP1 and human AK6 makes a sim-
ilar function of the proteins unlikely.of PfAK2 in the parasitophorous vacuole membrane. (B) Western blot of parasites
tion, anti-Hsp70 as a marker for the cytosolic fraction, and anti-GFP antibodies. (C)
G2A-GFP. Cytosol comprises erythrocyte cytosol and parasite cytosol; pellet includes
le membrane. Scale bar, 3 lm.
Fig. 5. Localization of PfAK2. (A) Co-localization of PfAK2-GFP with serine-rich protein (SERP). (B) A comparison of the localization of PfAK2-GFP with Bodipy-TR-ceramide
shows that the loops contain membraneous material. (C) Co-localization of PfAK2-GFP with Plasmodium falciparum exported protein (EXP1) by using an anti-Exp1 antibody.
Scale bar, 3 lm.
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AMP in vitro with a speciﬁc activity of3 mU/mg. That is similar to
its homolog human AK6, which has less than 1% activity (0.95 U/
mg) compared to human AK1 [13]. Although we tested various
NTP and NMP combinations and assay buffers with different pH
values (from 6 to 9) and removed the His-Tag, the activity of
PfAKLP1 remained low. This indicates that PfAKLP1 might exert
functions other than AK activity. However, except for similarity
to the AK superfamily, extensive sequence alignments only showed
similarities to hypothetical proteins with yet unknown functions.
Under the conditions tested in this study, an AK activity was not
detectable for PfAKLP2, thus suggesting that PfAKLP2 does not be-
long to the AK superfamily. As shown in Fig. 1, many amino acids
involved in substrate binding such as K70 that are essential for
activity in other AKs, are not conserved in PfAKLP2; this is consis-
tent with the missing AK activity. Besides that, the residues gener-
ally required for catalytic activity (Fig. 1) are missing. Apart from
K70, no residue of the P-loop is present. For PfAKLP2, the highest
sequence similarity was found with hypothetical proteins from
Plasmodium knowlesi and Plasmodium yoelii and a putative AK from
Plasmodium vivax. Moreover, PfAKLP2 is partially homologous –
from residue 20 to 173 with 50% similarity – to the AK isoform B
of T. brucei (Fig. 1) [14].
Considering its high energy demands and rapid multiplication,
Plasmodium requires an efﬁcient interconversion system of ade-
nine nucleotides. PfAK1 and PfAKLP1 are located in the cytosol,
where most of the energy is turned over. The mitochondrial local-
ization of PfGAK, which transfers the high-energy phosphate from
GTP to AMP, is consistent with the fact that GTP is produced in the
citric acid cycle in the mitochondrion [19]. A typical AK, using 2
ADP in the back reaction, would interfere with efﬁcient oxidative
phosphorylation in the mitochondrion.
N-myristoylation anchors proteins to a membrane in order to
mediate diverse functions such as signal transduction, protein
translocation, and cellular regulation [20,21]. A polybasic stretch
of amino acids or one or two palmitoylated cysteine residues closeto the myristoyl moiety attached to the protein is necessary for sta-
bilizing the membrane localization [22,23]. PfAK2 has an unusual
polybasic stretch of amino acids when compared to other AKs in
Plasmodium (Fig. 1). The G2A mutation of the N-myristoylation site
of PfAK2 demonstrated that N-myristoylation is required to bind
PfAK2 to the PVM, since the loss of the N-myristoylated glycine
alone changes the localization of the protein. Parasite proteins ex-
ported into the host erythrocyte must stay in an unfolded state,
and an important role for molecular chaperones has been sug-
gested in this context [24]. These chaperones are supposed to have
a considerable demand for adenine nucleotides. Considering the
central role of the parasitophorous vacuole membrane for protein
transport from the parasite to the host cell compartment, we
hypothesize that PfAK2 might be involved in the energy supply
of protein transport.
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